Show simple item record

dc.contributor.authorConsejo Ejecutivo, 124
dc.coverage.spatialGinebraen
dc.date.accessioned2011-11-18T19:20:15Z
dc.date.available2011-11-18T19:20:15Z
dc.date.issued2009
dc.identifier.govdocEB124/14
dc.identifier.govdocEB124/14 Corr.1
dc.identifier.urihttp://www.who.int/iris/handle/10665/2459
dc.description6 p.en
dc.descriptionConsejo Ejecutivo 124ª reunión, punto 4.11 del orden del día provisionalen
dc.language.isoesen
dc.publisherOrganización Mundial de la Saluden
dc.subjectPreparados farmacéuticosen
dc.subject.meshPharmaceutical Preparationsen
dc.subject.meshDrug Contaminationen
dc.subject.meshFrauden
dc.subject.meshLegislation, Drugen
dc.subject.meshCommerceen
dc.titleFalsificación de productos médicos: informe de la Secretaríaen
dc.typeGoverning body documentsen
dc.subject.meshqualifiersupply and distributionen
who.relation.languageVersion10665/2121en
who.relation.languageVersion10665/3333en
who.relation.languageVersion10665/3669en
who.relation.languageVersion10665/2935en
who.relation.languageVersion10665/3334en
who.relation.languageVersion10665/2960en
who.relation.languageVersion10665/2937en


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(‎s)‎

  • EB124
    19-27 January 2009

Show simple item record